American Oriental Bioengineering, Inc.  

(Public, OTCMKTS:AOBI)   Watch this stock  
Find more results for COSIMO PATTI
0.00 (0.00%)
Dec 18 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol / Avg. 78.00/58.00
Mkt cap 182,719.00
P/E     -
Div/yield     -
EPS     -
Shares 72,771.00
Beta 1.14
Inst. own 0%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -118.06% -
Operating margin -105.78% -
EBITD margin - -
Return on average assets -20.07% -5.15%
Return on average equity -29.01% -7.34%
Employees 3,719 -
CDP Score - -


1 Liangshuihe First Avenue Beijing E-Town Ecnmc & Tech Dvlpmnt Area E-Town
+86-10-59822039 (Phone)
+86-10-87857429 (Fax)

Website links

External links

Transcripts - SeekingAlpha


American Oriental Bioengineering, Inc. is an integrated pharmaceutical company. The Company is engaged in development, manufacture and commercialization of a broad range of pharmaceutical and healthcare products. The Company�s products are manufactured using plant based materials. The Company�s business is consists of prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products. The Company�s pharmaceutical products were approved by the Chinese State Food and Drug Administration (SFDA). The Company�s sell its products primarily to hospitals, clinics, pharmacies and retail outlets in all provinces, including rural areas and cities in China. During the year ended December 31, 2012, the Company market 158 pharmaceutical products in China.

Officers and directors

Shujun Liu Chairman of the Board, Chief Executive Officer
Age: 59
Yanchun Li Chief Financial Officer, Secretary, Director
Age: 43
Xiaopeng Xu Chief Operations Officer
Age: 63
Yan Gao Chief Accounting Officer
Age: 40
Jun Min Vice President, Director
Age: 55
Cosimo J. Patti Independent Director
Age: 62
Xianmin Wang Independent Director
Age: 69
Baiqing Zhang Independent Director
Age: 59